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Cloning of hybrid PKS modules 
The cloning, expression, and purification of Pik Mod5[1], Pik Mod5-PikTE[2], Pik Mod6[1], Pik TE[3], 
DEBS Mod5[4], DEBS Mod5-DEBS TE[4], DEBS Mod6[4], DEBS TE[5], Juv Mod6[6], and Juv Mod7[6] 
have been previously reported. Pik Mod6, DEBS Mod6, Juv Mod6, and Juv Mod7 hybrids were 
generated by inserting a restriction site at the 3’ end of the alignment consensus for each 
antiSMASH7 annotated ACP domain to enable insertion of the respective non-native TE domains 
(Figure S1). 
 
The hybrid TE proteins utilized in this study were generated by the following procedures: 
 
The Juv TE domain region was determined by sequence alignment to Pik and DEBS and PCR 
amplified from pET21-Juv Mod7 using primers 5’-ccaaccgaattcaccggcgcggcgggcgggccacc-3’ and 
5’-ccaaccctcgagtcatgcggccgcaagcttcggaacgcg-3’ and subsequently inserted into pET28b using 
EcoRI and XhoI. This construct was then used as the template for two rounds of mutagenesis 
following the QuikChange site-directed mutagenesis (Stratagene) protocol to remove an internal 
BamHI site using primers 5’- ggggcctggccggacccccggcaggactg-3’ and 5’-
cagtcctgccgggggtccggccaggcccc-3’, and HindIII site using primers 5’-
gtgcggccgcaagtttcggaacgcgag-3’ and 5’-cgcctggcggtaccggatcgcctggc-3’. This modified construct 
was then used for generating the Juv TE hybrid PKS modules as described below.  
 
Pik Mod5-TE hybrids: 
pET24b Pik Mod5-Pik TE[2] was digested with HindIII and XhoI to allow for fusion with the DEBS 
TE using primers 5’-ccaaccaagcttagcgggactcccgcccgggaagcg-3’ and 5’-
ccaaccctcgagtgaattccctccgcccagccaggc-3’, and Juv TE using primers 5’-
ccaaccaagcttaccggcgcggcgggcgggccacc-3’ and 5’-ccaaccctcgagtgcggccgcaagcttcggaacgcg-3’.  
 
Pik Mod6–TE hybrids: 
The Pik Mod6-TE hybrids were constructed from pET24b Pik Mod6[1] in two steps. First, Pik Mod6 
was truncated at the 3’ end to its corresponding ACP domain by digestion with EcoRI and HindIII 
followed by ligation with a similarly digested PCR amplification product generated using primers 
5’-gacagctcacccgaattc-3’ and 5’-ccaaccaagcttcagctcgtcgctgatgcgctcggc-3’. Next this 
intermediate was digested with HindIII and XhoI to allow for fusion with the DEBS TE using 
primers 5’-ccaaccaagcttagcgggactcccgcccgggaagcg-3’ and 5’-
ccaaccctcgagtgaattccctccgcccagccaggc-3’, and the Juv TE using primers 5’-
ccaaccaagcttaccggcgcggcgggcgggccacc-3’ and 5’-ccaaccctcgagtgcggccgcaagcttcggaacgcg-3’.  
 
DEBS Mod5-TE hybrids: 
pET28b DEBS Mod5-DEBS TE[4] was digested with BamHI and XhoI to allow for fusion with Pik 
TE using primers 5’-ccaaccggatcctccggggccgacaccggc-3’ and 5’-
ccttccctcgagtcagcccgccccctcgatgcc-3’, DEBS TE using primers 5’-
ccaaccggatccagcgggactcccgcccgggaagcg-3’ and 5’-ccaaccctcgagtcatgaattccctccgcccagccaggc-
3’, and Juv TE using primers 5’-ccaaccggatccaccggcgcggcgggcgggccacc-3’ and 5’-
ccaaccctcgagtcatgcggccgcaagcttcggaacgcg-3’.  
 
DEBS Mod6-TE hybrids: 
The DEBS Mod6-TE hybrids were constructed from pET24b DEBS Mod6[4] in two steps. First, 
DEBS Mod6 was truncated at the 3’ end to its corresponding ACP domain by digestion with XbaI 
and EcoRI followed by ligation with a similarly digested PCR amplification product generated 
using primers 5’-cccctctagaaataattttgtttaactttaagaagg-3’ and 5’-
ccaaccgaattcgagctgctgtcctatgtggtcg-3’. Next this intermediate was digested with EcoRI and 
HindIII to allow for fusion with the Pik TE using primers 5’-ccaaccgaattctccggggccgacaccggc-3’ 
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and 5’-ccaaccaagcttgcccgccccctcgatgcc-3’, and the Juv TE using primers 5’-
ccaaccgaattcaccggcgcggcgggcgggccacc-3’ and 5’-ccaaccaagctttgcggccgcaagcttcggaacgcg-3’.  
 
Juv Mod6-TE hybrids: 
The Juv Mod6-TE hybrids were constructed from pET28b Juv Mod6[6] in two steps. First, Juv 
Mod6 was truncated at the 3’ end to its corresponding ACP domain by digestion with NdeI and 
HindIII followed by ligation with a similarly digested PCR amplification product generated using 
primers 5’- ccaacccatatgtcgaacgagcagaagctccgc-3’ and 5’- 
ccaaccaagcttgagcagcccggccaggtgctcggc-3’. Next this intermediate was digested with HindIII and 
XhoI to allow for fusion with the Pik TE using primers 5’- ccaaccaagctttccggggccgacaccggc-3’ 
and 5’- ccaaccctcgagtcacttgcccgccccctcga-3’, the DEBS TE using primers 5’- 
ccaaccaagcttagcgggactcccgcccgggaagcg-3’ and 5’- ccaaccctcgagtcatgaattccctccgcccagccaggc-
3’, and the Juv TE using primers 5’- ccaaccaagcttaccggcgcggcgggcgggccaacc-3’ and 5’- 
ccaaccctcgagtcatgcggccgcaagcttcggaacgcg-3’.  
 
Juv Mod7-TE hybrids: 
The Juv Mod7-TE hybrids were constructed from pET21b Juv Mod7[6] in two steps. First, Juv 
Mod7 was truncated at the 3’ end to its corresponding ACP domain by digestion with KpnI and 
HindIII followed by ligation with a similarly digested PCR amplification product generated using 
primers 5’- cgcctggcggtaccggatcgcctggc-3’ and 5’- ccaaccaagcttgagcaggccgtgcaggtgcgcggc-3’. 
Next this intermediate was digested with HindIII and XhoI to allow for fusion with the Pik TE using 
primers 5’- ccaaccaagctttccggggccgacaccggc-3’ and 5’- ccaaccctcgagcttgcccgccccctcga-3’, and 
the DEBS TE using primers 5’- ccaaccaagcttagcgggactcccgcccgggaagcg-3’ and 5’- 
ccaaccctcgagtgaattccctccgcccagccaggc-3’.    
 
Juv Mod6 PikTES148A:  
The JuvMod6 PikTES148A was constructed from pET28b JuvMod6 PikTE and pET28 PikTES148A in 
two steps. First, PikTES148A was amplified to contain an N terminal HindIII site 5’-
CCAACCAAGCTTTCCGGGGCCGACACCGGC – 3’ and an XhoI site 5’- 
CCAACCCTCGAGTCACTTGCCCGCCCCCTCGA – 3’. Both the amplicon and the pET28b 
JuvMod6 PikTE were digested with HindIII and XhoI with subsequent ligation yielding the desired 








Figure S1. Determination of the post-ACP restriction site (black arrow) for incorporating non-
native TE domains. The location was chosen from alignment of the antiSMASH7 annotated ACP 
domain regions (orange highlight) for each PKS module. Sequences were aligned using T-coffee8 
and rendered with ESPript9.   
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PKS protein biochemistry 
E. coli cell culture, protein purification, and enzymatic reactions were performed using water 
obtained from a Millipore Milli-Q system with Millipore Q-Gard 2/Quantum Ex Ultrapure organex 
cartridges. E. coli culture growth was performed in 15 mL sterile tubes for the seed cultures and 
2.8 L Corning Fernbach flasks with deep baffles (3x) for protein expression cultures. Reagents 
were obtained from the following sources: LB broth (Miller) and glycerol was obtained from EMD. 
Isopropyl-β-D-thiogalactopyranoside (IPTG), Kanamycin sulfate (Kan), and Ampicillin (Amp) were 
obtained from Gold Biotechnology. NaCl, CaCl2 and imidazole were obtained from Fisher 
Scientific. Lysozyme was purchased from RPI, PD-10 colums were purchased from GE scientific, 
and Ni-NTA agarose resin was purchased from Qiagen. The pH of all solutions was monitored 
via a Symphony SB70P pH meter calibrated according to the manufacturer’s specifications. 
Optical density (OD600) was determined using an Eppendorf Biophotometer and E. coli cell lysis 
was accomplished using a 550 Sonic Dismembrator (Fisher Scientific). All solutions were 
autoclaved or sterile filtered (0.2 µm) prior to use.  
 
Buffers: 
lysis: HEPES (50 mM), NaCl (300 mM), imidazole (10 mM), glycerol (10% v/v), pH 8.0.  
wash: HEPES (50 mM), NaCl (300 mM), imidazole (30 mM), glycerol (10% v/v), pH 8.0.  
elution HEPES (50 mM), NaCl (300 mM), imidazole (300 mM), glycerol (10% v/v), pH 8.0.  
storage: HEPES (50 mM), NaCl (150 mM), EDTA (1 mM), glycerol (20% v/v), pH 7.2.  
Stock solutions:  
hexaketide substrates (50 mM in DMSO), 2-vinylpyridine (500 mM in DMSO), ascorbic acid (500 
mM in H2O), sodium metabisulfite (100 mM in H2O). 
 
Protein production 
A starter culture was generated by inoculating 5 mL of LB broth containing Kan or Amp (50 mg/L) 
with fresh transformants of E. coli (BAP1)[8] cells containing the corresponding plasmids for 
expression of the respective PKS proteins and grown overnight at 37 ˚C. Following overnight 
growth, the entire starter culture was subsequently used to inoculate an expression culture of 1 L 
of TB containing Kan or Amp (50 mg/L) and grown at 37 ˚C to an OD600 of 0.3-0.4. The expression 
cultures were then cooled to 18 ˚C and growth was maintained until an OD600 of 0.7-0.8 was 
reached, at which point protein expression was induced via addition of IPTG (350 µM) and the 
cultures were incubated at 200 RPM at 18 ˚C for 20 hours.  
 
Protein purification 
A single pass purification scheme was employed to minimize the length of time each protein was 
processed since previous work has shown the most reproducible in vitro activity is achieved with 
short purification times.[9] Purification by Ni-NTA affinity chromatography provided each protein in 
yields (Table S1) and purities (Figure S2) sufficient for enzymatic analysis. Although the Juv Mod6 
hybrids contained significant contaminating species within the purified protein fractions (lanes 13-
16, Figure S2), our previous study[6] had shown Juv Mod6 retains high catalytic efficiency as a 




Protein expression cultures were cooled to 4 ˚C and harvested by centrifugation (6,500 x g, 10 
min, 4 ˚C). The pelleted cells were then suspended in 5 mL of lysis buffer per gram of cells via 
vortex. Cell lysis was accomplished by the addition of 0.4 mg/mL lysozyme and the solution was 
then sonicated on ice (100 x 3s with 10s rest periods). The resulting cellular lysate was then 
pelleted by centrifugation (60,000 x g, 30 min, 4 ˚C) and the supernatant was applied to 6 mL of 
pre-equilibrated Ni-NTA resin. After binding, the column was washed with 15 column volumes of 
wash buffer and the target protein was subsequently eluted with 4 column volumes of elution 
buffer. Elution fractions were determined by their absorption at 280 nm, pooled, and buffer 
exchanged into storage buffer using a pre-equilibrated PD-10 column. After buffer exchange, the 
elution fractions were once again monitored via their absorption at 280 nm, pooled, flash frozen 













Figure S2 NuPAGE® Bis-Tris Mini gel of purified PKS modules in MOPS running buffer 
with BenchMark™ Pre-stained Protein Ladder. Lanes: 1. Pik Mod5-DEBS TE (186 
kDa), 2. Pik Mod5-Juv TE (186 kDa), 3. Pik Mod5-Pik TE (187 kDa), 4. Pik Mod6-DEBS 
TE (138 kDa), 5. Pik Mod6-Juv TE (139 kDa), 6. Pik Mod6-Pik TE (143 kDa), 7. DEBS 
Mod5-DEBS TE (186 kDa), 8. DEBS Mod5-Juv TE (187 kDa), 9. DEBS Mod5-Pik TE 
(188 kDa), 10. DEBS Mod6-DEBS TE (178 kDa), 11. DEBS Mod6-Juv TE (178 kDa), 
12. DEBS Mod6-Pik TE (179 kDa), 13. Juv Mod6 (165 kDa), 14. Juv Mod6-DEBS TE 
(187 kDa), 15. Juv Mod6-Juv TE (188 kDa), 16. Juv Mod6-Pik TE (189 kDa), 17. Juv 




Enzymatic reactions  
All analytical scale reactions were performed in triplicate at a volume of 50 μL and quenched with 
3 volumes of MeOH (150 μL), clarified by centrifugation (17,000 x g, 30 min, 4 ˚C) and analyzed 
for product formation by HPLC. 2-vinylpyridine (Sigma) was employed as a thiol scavenger.  
 
Reactions containing NBOM protected Pik hexaketide[10] were performed in two steps. First, a 
solution containing ascorbic acid (25mM final concentration), sodium metabisulfite (1mM final 
concentration), NBOM protected substrate (1mM final concentration), and H2O (requisite dead 
volume) was irradiated under a consumer facial tanning lamp at a height of 14 cm (Verseo 
#AH129c) for 20 min to furnish the deprotected Pik hexaketide 2. After photolysis, the solution 
was diluted with reaction buffer and catalysis was initiated via the addition of enzyme and 
incubated for 4 hours.   
 
HPLC analysis 
Macrolactone production was monitored via analytical high-performance liquid chromatography 
(HPLC) using a Shimadzu LC-20AD instrument.  
 
Product formation in Table 1 was quantified using Phenomenex Luna 5μ C18 250 x 4.6 mm 
column (serial 466013-1) monitoring at a wavelength of 236 nm. Separation was accomplished 
by the following method: 1.5 mL/min, solvent A: H2O + 0.1% formic acid, solvent B: MeCN + 0.1% 
formic acid, 5% B 0-1 min, 5-100% B linear gradient 1-12 min, 100% B 12-15 min, 5% B 15-17.5 
min.  
  
Product formation in Table 2 and 3 was quantified using a Zorbax SB-Phenyl 3.5 μM 4.6 x 150 
mm column (part number 863953-912) monitoring at a wavelength of 236 nm. Separation was 
accomplished by the following method: 3.0 mL/min, solvent A: H2O + 0.1% formic acid, solvent B: 
MeCN + 0.1% formic acid, 5% B 0-1 min, 5-70% B linear gradient 1-13 min, 100% B 13-15 min, 
5% B 15-17 min. 
 
LC-HRMS analysis  
Analytical liquid chromatography-mass spectrometry (LC-MS) was performed on an Agilent LC 
system (1290 series) coupled to an Agilent QTOF mass spectrometer (6500 series) using a 
Phenomenex Synergi 4μ Hydro RP 100 x 2 mm column (serial 48836-5) heated to 50°C. Method: 
0.4 mL/min, solvent A: H2O + 0.1% formic acid, solvent B: MeCN + 0.1% formic acid, 0% B 0-2 
min,0-100% B linear gradient 2-10 min, 100% 10-11 min, 0% B 11-12 min, 0-1 min were diverted 




Figure S3: TIC LC-HRMS analysis of JuvMod6-PikTE time course showing disappearance of 
starting material and appearance of a substance corresponding to the linear acid or hemiketal 
species (compounds 11 and/or 12). In a time-dependent manner, the level of 11/12 (red line) is 





Figure S4: LC-HRMS analysis (UV extracted at 285 nm) of isolated 11/12 mixture under 
enzymatic reaction buffered conditions (see below) over time with and without enzyme in 
comparison to original reaction of 3 to 13. Analysis indicates that the original reaction consumes 
starting material in two hours with clear formation of 13 after 4 hours (Trace A). Compounds 11/12 
display turnover to the dehydrated pyran 13 in a similar time-dependent manner with (Trace C) 
and without (Trace B) Juv Mod6-Pik TE. Continued time points not displayed for the original 
reaction (3 +JuvMod6-PikTE) shows an increase in 13 over the 12-hour period (Figure S3). 





























Reaction conditions: sodium phosphate buffer (400 mM, 20% v/v glycerol, 92 mL total, pH = 7.2), 
Pik hexaketide 2 (51 mg, 0.09 mmol, 1 mM), MM-SNAC (20 equiv, 20 mM), NADP+ (0.5 equiv, 
0.5 mM), glucose-6-phosphate (2.5 equiv, 2.5 mM), glucose-6-phosphate dehydrogenase (2 
units/mL), 2-vinylpyridine (8 mM), ascorbic acid (25 mM), sodium metabisulfite (1 mM), DEBS 
Mod6-DEBS TE (1 μM, 0.1 mol%), 20 hours, stationary, RT.  
 
Workup and purification: Quenched with acetone (2x volume, 184 mL), placed in a -20 °C freezer 
for 1 h and filtered through a celite plug.  Remaining insoluble material was suspended in acetone 
and this solution was used to rinse the celite plug.  Acetone was removed through rotary 
evaporation and the aqueous layer was saturated with NaCl and extracted 3x EtOAc. Combined 
organic layers were concentrated. 7 was purified directly by preparatory HPLC using a 
Phenomenex Luna 5u C18 250 x 21.2mm column (serial 444304-4) monitoring at 250nM. Method 
9mL/min, A: H2O + 0.1% formic acid, B: MeCN + 0.1% formic acid, 5% B 0-5 min, 5-100% B linear 
gradient 5-45 min, 100% B 45-65 min, 5% 65-75 min.  
 
7 from Pik hexaketide 2 (4.1 mg, 0.089 mmol, 12.6% yield). 
1H NMR (700 MHz, CD3OD) δ 7.11 (dd, J = 15.9, 4.5 Hz, 1H), 6.27 (dd, J = 15.9, 2.0 Hz, 1H), 
5.10 (ddd, J = 9.4, 4.5, 1.8 Hz, 1H), 3.44 (dd, J = 9.0, 1.5 Hz, 1H), 3.41 (dd, J = 7.2, 1.3 Hz, 1H), 
2.69 (ddd, J = 8.7, 4.3, 2.0 Hz, 1H), 2.63 (ddd, J = 10.8, 7.0, 4.0 Hz, 1H), 2.55 (m, 1H), 1.78 (m, 
1H), 1.76 (ddd, J = 14.1, 7.0, 4.9 Hz, 1H), 1.63 (ddd, J = 14.0, 7.4, 4.6 Hz, 1H), 1.41 – 1.35 (m, 
1H), 1.31 – 1.26 (m, 1H), 1.25 (s, 1H), 1.22 (d, J = 4.0 Hz, 1H), 1.20 (t, J = 4.4 Hz, 1H), 1.18 (d, 
J = 6.9 Hz, 3H), 1.15 (d, J = 6.9 Hz, 3H), 1.13 (d, J = 6.8 Hz, 3H), 1.03 (d, J = 6.7 Hz, 3H), 0.95 
(m, 3H), 0.93 (d, J = 7.4 Hz, 2H). 
13C NMR (700 MHz; CD3OD) δ 206.07, 177.72, 152.84, 124.72, 78.40, 78.10, 75.00, 45.90, 
45.30, 42.93, 40.80, 37.45, 35.71, 26.52, 19.41, 18.03, 15.61, 10.92, 10.34, 8.92.  


















Reaction conditions: sodium phosphate buffer (400 mM, 20% v/v glycerol, 204 mL total, pH = 
7.2), Tyl hexaketide 3 (41 mg, 0.10 mmol, 0.5 mM), MM-SNAC (20 equiv, 10 mM), NADP+ (0.5 
equiv, 0.25 mM), glucose-6-phosphate (2.5 equiv, 1.25 mM), glucose-6-phosphate 
dehydrogenase (2 units/mL), Juv Mod6 (4 μM, 0.8 mol%), 20 hours, stationary, RT.  
 
Workup and purification:  Quenched with acetone (2x volume, 400 mL), placed in a -20 °C 
freezer for 1 h and filtered through a celite plug.  Remaining insoluble material was suspended 
in acetone and this solution was used to rinse the celite plug.  Acetone was removed through 
rotary evaporation and the aqueous layer was saturated with NaCl and extracted 3x EtOAc. 
Combined organic layers were concentrated. 13 was purified directly by preparatory HPLC 
using a Phenomenex Luna 5u C18 250 x 21.2mm column (serial 444304-4) monitoring at 
250nM. Method 9mL/min, A: H2O + 0.1% formic acid, B: MeCN + 0.1% formic acid, 5% B 0-5 
min, 5-100% B linear gradient 5-45 min, 100% B 45-65 min, 5% 65-75 min. 
 
13 from Tyl hexaketide 3 (4.2 mg, 0.01 mmol, 11.7% yield). 
1H NMR (700 MHz, CD3OD) δ 6.49 (d, J = 15.5 Hz, 1H), 6.21 (d, J = 15.5 Hz, 1H), 5.46 (d, J = 
9.8 Hz, 1H), 3.95 – 3.91 (m, 1H), 3.37 – 3.34 (m, 1H), 2.79 – 2.73 (m, 1H), 2.64 – 2.59 (m, 1H), 
2.23 (dd, J = 18.0, 6.2 Hz, 1H), 1.86 – 1.79 (m, 2H), 1.78 (s, 2H), 1.73 (s, 2H), 1.69 – 1.64 (m, 
2H), 1.57 – 1.51 (m, 2H), 1.47 – 1.41 (m, 2H), 1.39 – 1.33 (m, 2H), 1.17 (d, J = 6.9 Hz, 2H), 
1.00 (d, J = 6.9 Hz, 2H), 0.96 (t, J = 7.5 Hz, 2H), 0.93 (t, J = 7.4 Hz, 3H). 
13C NMR (700 MHz; CD3OD) δ 178.84, 145.04, 136.20, 135.13, 133.34, 118.42, 108.00, 79.91, 
78.19, 42.17, 39.55, 36.59, 33.35, 28.38, 25.59, 17.60, 17.40, 12.83, 11.43, 11.26, 10.90. 









COSY and HMBC correlations seen from easily discernable, single peak hydrogens. 
Overlapping signals as well as clear correlations from obscured hydrogens are denoted in the 
table. NMRs taken in D-6 Acetone. 
 
 
 Peaks assigned based on relative height  
 May be interchanged between isomers  
 Signals cannot be unambiguously assigned due to heavy overlap  









COSY and HMBC correlations seen from easily discernable, single peak hydrogens. 
Overlapping signals as well as clear correlations from obscured hydrogens are denoted in the 
table. NMRs taken in D-6 Acetone 
 
 Peaks assigned based on relative height  
 May be interchanged between isomers 
 Signals cannot be unambiguously assigned due to heavy overlap  







COSY and HMBC correlations seen from easily discernable, single peak hydrogens. 
Overlapping signals as well as clear correlations from obscured hydrogens are denoted in the 
table. NMRs taken in D-6 Acetone 
 
 Peaks assigned based on relative height  
 May be interchanged between isomers 
 Signals cannot be unambiguously assigned due to heavy overlap  






COSY and HMBC correlations seen from easily discernable, single peak hydrogens. 
Overlapping signals as well as clear correlations from obscured hydrogens are denoted in the 
table. NMRs taken in D-6 Acetone 
 
 Peaks assigned based on relative height  
 Protons cannot be unambiguously assigned, may be interchanged between isomers 





Obs. Indicates the peak is obscured but is visibly present due to 2D correlations in 
the designated rang 
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